BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 4437565)

  • 1. [The rapid determination of fibrin and fibrinogen split products with a bedside thrombin coagulase time test in obstetric coagulopathies (author's transl)].
    Kastendieck E; Barthels M
    Geburtshilfe Frauenheilkd; 1974 Sep; 34(9):758-62. PubMed ID: 4437565
    [No Abstract]   [Full Text] [Related]  

  • 2. [Assessment of circulating soluble fibrin by the ethanol test during delivery (author's transl)].
    Tascon A; Aznar JA; Mayans JR; Martinez J; Soler A; Marty ML
    Sangre (Barc); 1977; 22(2):191-6. PubMed ID: 854834
    [No Abstract]   [Full Text] [Related]  

  • 3. Dysfibrinogenemia in a patient with primary hepatoma. First observation of an acquired abnormality of fibrin monomer aggregation.
    von Felten A; Straub PW; Frick PG
    N Engl J Med; 1969 Feb; 280(8):405-9. PubMed ID: 4303132
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the diagnosis of blood coagulation disorders in obstetrics by means of the thrombin time determination].
    Slunský R; Kalita Z; Adamcová M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 91(4):465-71. PubMed ID: 4184473
    [No Abstract]   [Full Text] [Related]  

  • 5. [Estimation of soluble fibrin monomer complexes for evaluation of hypercoagulability during pregnancy and delivery (author's transl)].
    Hafter R; Schneebauer T; Tafel K; Ernst E; Graeff H
    Geburtshilfe Frauenheilkd; 1975 Jul; 35(7):518-25. PubMed ID: 1213264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reliability of tests for fibrinogen (fibrin) degradation products in plasma with thrombin coagulase, reptilase and thrombin clotting time (author's transl)].
    Wenzel E; Holzhüter H; Muschietti F; Angelkort B; Ochs HG; Pusztai-Markos S; Nowak H; Stürner H
    Dtsch Med Wochenschr; 1974 Apr; 99(15):746-56. PubMed ID: 4858105
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of prophylactic heparin treatment on enhanced thrombin generation in pregnancy.
    Bremme K; Lind H; Blombäck M
    Obstet Gynecol; 1993 Jan; 81(1):78-83. PubMed ID: 8416465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test.
    Hawiger J; Niewiarowski S; Gurewich V; Thomas DP
    J Lab Clin Med; 1970 Jan; 75(1):93-108. PubMed ID: 4243578
    [No Abstract]   [Full Text] [Related]  

  • 9. Laboratory identification of intravascular coagulation. The serial dilution protamine sulfate test for the detection of fibrin monomer and fibrin degradation products.
    Niewiarowski S; Gurewich V
    J Lab Clin Med; 1971 Apr; 77(4):665-76. PubMed ID: 4928905
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnostic of blood coagulation].
    Barthels M
    Hamostaseologie; 2008 Dec; 28(5):320-34. PubMed ID: 19132163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A comprehensive laboratory evaluation of changes in the fibrinogen molecule in the diagnosis of acquired coagulopathy conditions].
    Siatkovskiĭ VA; Azarova LA; Vasilenko PL
    Lab Delo; 1989; (8):45-8. PubMed ID: 2477628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute blood coagulation disorders in obstetrics].
    Graeff H; Hafter R; Hugo RV
    Med Welt; 1978 Feb; 29(6):212-6. PubMed ID: 622027
    [No Abstract]   [Full Text] [Related]  

  • 13. [The coagulation system in Rivanol-induced abortion (author's transl)].
    Olund A; Bistoletti P
    Zentralbl Gynakol; 1980; 102(9):507-12. PubMed ID: 6781170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Different aspects of the defibrinization syndrome in gynecology-obstetrics].
    La Selve A; Le Petit JC; Vial JY; Brizard CP
    J Med Lyon; 1970 Jun; 51(188):1271-2 passim. PubMed ID: 5479123
    [No Abstract]   [Full Text] [Related]  

  • 15. Split products of fibrin in maternal serum in the perinatal period.
    Stiehm ER; Kennan AL; Schelble DT
    Am J Obstet Gynecol; 1970 Nov; 108(6):941-5. PubMed ID: 5486486
    [No Abstract]   [Full Text] [Related]  

  • 16. [An analysis of a disorder in the fibrin-forming phase in virtually healthy middle-aged and elderly subjects by using the ancistron test].
    Platonova TN; Sushko OO; Lukinova NI; Solovĭov DA
    Fiziol Zh (1994); 1994; 40(3-4):63-70. PubMed ID: 7621957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of blood coagulation disorders].
    Porchia NL
    Matern Infanc (Sao Paulo); 1968; 27(4):349-55. PubMed ID: 5728525
    [No Abstract]   [Full Text] [Related]  

  • 18. [Efficiency and limits of blood coagulation tests].
    Róka L
    Internist (Berl); 1973 Apr; 14(4):149-53. PubMed ID: 4577209
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative investigation of the determination of fibrinogen (author's transl)].
    Schander K; Schneider J; Ventocilla B
    Geburtshilfe Frauenheilkd; 1974 Sep; 34(9):763-6. PubMed ID: 4437566
    [No Abstract]   [Full Text] [Related]  

  • 20. [Congenital dysfibrinogenaemia. Two new cases (author's transl)].
    Amsellem M; Samama M; Conard J; Levyne S; Ohlgiesser C
    Nouv Presse Med; 1978 Nov; 7(41):3745-8. PubMed ID: 733523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.